Bellbrook Labs, LLC
Chemically induced dimerization (CID) assay systems for detecting small molecule enzyme products in high-throughput screening
- Sector
- Biotech
- Headquarters
- MADISON, WI
- Latest Form D
- $200K, Nov 2018
- Total capital
- $7.4M
- Federal grants
- $7M
- 15 awards · 2015–2024
- Rank in peer group#8 of 42
- Private capital raised
- $387K
- 2 Form D · last Nov 2018
- 95 months since last filing
- Federal contracts
- $90K
- 1 award · Commerce
- Rank in Biotech#335 of 4373
- Granted patents
- 0
- 18 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Chemically Induced Dimerization Systems for High Throughput Enzyme Assays$271K
- Federal grantHealth and Human S · Phase II · Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases$832K
- Federal grantHealth and Human S · Phase II · Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases$989K
- Federal grantHealth and Human S · Phase I · Discovery of TREX1 Antagonists for Cancer Immunotherapy$300K
- Federal grantHealth and Human S · Phase II · HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer$329K
- Federal grantHealth and Human S · Phase I · Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases$300K
- Federal grantHealth and Human S · Phase II · HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer$416K
- Private capital raisedForm D · SEC · 2nd filing$200K
- Private capital raisedForm D · SEC · 1st filing$187K
Show 9 earlier federal awards
- Federal grantHealth and Human S · Phase II · HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer$1.3M
- Federal grantHealth and Human S · Phase I · HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer$289K
- Federal grantHealth and Human S · Phase II · Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery$390K
- Federal grantHealth and Human S · Phase I · Pharmacological Validation of GIV/Girdin, a Guanine Nucleotide Exchange Factor, for Liver Fibrosis$353K
- Federal grantHealth and Human S · Phase I · Streamlining HTS Assay Development through Direct Selection of Structure-Switching Aptamers$235K
- Federal grantHealth and Human S · Phase II · Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery$470K
- Federal grantHealth and Human S · Phase I · Axonal Transport HTS Platform for Neurodegeneration Drug Discovery$225K
- Federal grantHealth and Human S · Phase I · Fluorescent biosensors for dynamic monitoring of paracrine signaling in extracellular matrix$225K
- Federal contractCommerce · SBIR Phase I$90K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
23months
from Bellbrook Labs, LLC’s first federal award to its first private round.
- First federal award · Jul 2010
- Commerce · $90K
- First Form D · Jun 2012
- $187K · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 42 peers
Line = medianBiotech · Instrument
- Federal grants#8 · top 19%
- Linked publications#8 · top 19%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Robert G. LoweryResearcherExecutive Officer, Director, PromoterLinked by $1.6M in grants as PI
- Don G. KennedyDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 18- PendingINHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTSUSPTOApplication 18275190
- PendingInhibitors Of Cgas Activity As Therapeutic AgentsUSPTOApplication 17419833
- PendingInhibitors Of Cgas Activity As Therapeutic AgentsUSPTOApplication 17419837
Show all 18 patent records
- INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTSMay 30, 2024 · Application 18275190Pending
- Inhibitors Of Cgas Activity As Therapeutic AgentsMar 10, 2022 · Application 17419833Pending
- Inhibitors Of Cgas Activity As Therapeutic AgentsMar 10, 2022 · Application 17419837Pending
- INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTSApplication 63396653Pending
- INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTSApplication PCTUS2022016073Pending
- Inhibitors Of Cgas Activity As Therapeutic AgentsApplication PCTUS2020012243Pending
- Inhibitors Of Cgas Activity As Therapeutic AgentsApplication PCTUS2020012250Pending
- Device For Washing Suspended Cells Or ParticlesApplication PCTUS2012039873Pending
- Surface-tension Based Flow Guidance In A Microstructure EnvironmentApplication PCTUS2012020808Pending
- Microfluidic Device Having Stable Static Gradient For Analyzing ChemotaxisApplication PCTUS2008082883Pending
- Assay Method For Group Transfer ReactionsApplication PCTUS2007088111Pending
- Assay Method For Group Transfer ReactionsApplication PCTUS2005018645Pending
- Three Dimensional Cell Cultures In A Microscale Fluid Handling SystemApplication PCTUS2004014092Pending
- Assay Method For Group Transfer ReactionsApplication PCTUS2004002618Pending
- IMIDAZOLYL-ALKOXYQUINOLIN-2-AMINESApplication PCTUS2023034542Pending
- INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTSApplication 19101476Pending
- Inhibitors Of Cgas Activity As Therapeutic AgentsApplication PCTUS2023029595Pending
- IMIDAZOLYL-ALKOXYQUINOLIN-2-AMINESApplication 63414341Pending
Recent research by its founders
- A sorghum pangenome reference improves global crop trait discovery20267 cites
- Abstract 460: A generic, high throughput unwinding assay for discovery of RNA helicase inhibitors.20260 cites
- Abstract 480: An HTS assay for detection of XRN1 exoribonuclease activity with unmodified RNA.20260 cites
Related companies, and why
- ADVAITA CORPSimilar federal contract value in Biotech · $97K in contracts
- Data2Discovery IncSimilar federal contract value in Biotech · $97K in contracts
- FLUENT BIOSCIENCES INCSimilar federal contract value in Biotech · $96K in contracts
- FINA BIOSOLUTIONS LLCSimilar federal contract value in Biotech · $83K in contracts
- Celularity IncSimilar federal contract value in Biotech · $80K in contracts
- AUM LIFETECH INCSimilar federal contract value in Biotech · $80K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .